The toll of not screening for colorectal cancer

Expert Rev Gastroenterol Hepatol. 2017 Jan;11(1):1-3. doi: 10.1080/17474124.2017.1264269. Epub 2016 Nov 29.

Authors

Chen Chen¹, Michael Hoffmeister¹, Hermann Brenner^{1

2

3}

Affiliations

¹ a Division of Clinical Epidemiology and Aging Research , German Cancer Research Center (DKFZ) , Heidelberg , Germany.
² b Division of Preventive Oncology , German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) , Heidelberg , Germany.
³ c German Cancer Consortium (DKTK) , German Cancer Research Center (DKFZ) , Heidelberg , Germany.

PMID: 27897033
DOI: 10.1080/17474124.2017.1264269

No abstract available

Keywords: Colorectal cancer; colonoscopy; fecal occult blood test; incidence; mortality; screening; sigmoidoscopy.

Publication types

Editorial

MeSH terms

Biomarkers, Tumor / analysis
Colonoscopy* / standards
Colorectal Neoplasms / chemistry
Colorectal Neoplasms / diagnosis*
Colorectal Neoplasms / epidemiology
Early Detection of Cancer / methods*
Early Detection of Cancer / standards
Feces / chemistry
Guideline Adherence
Healthcare Disparities
Humans
Immunohistochemistry* / standards
Patient Compliance*
Practice Guidelines as Topic
Practice Patterns, Physicians'* / standards
Predictive Value of Tests
Risk Factors

Substances

Biomarkers, Tumor